iGEM Foundation, CC BY 2.0 (https://creativecommons.org/licenses/by/2.0/deed.en)
Members of the iGEM Team Munich: Deepak Kumar, Finn Lueth, Igor Koop, Jonathan Costa, Lara Weber, Lilly May, Melike Sabry, Rosa Reithmeir, Till Gundlach and Ziwei Wang
Zoom in
A Munich student team won a Gold Medal in the world's largest academic competition for the field of Synthetic Biology with their project aimed at improving cell therapies against cancer. The group from the Technical University of Munich (TUM) and Ludwig Maximilian University of Munich (LMU) was the only German team to finish among the top 10 out of 180 student projects in the undergraduate age category.
Cancer is one of humanity's most acute health problems. According to the World Health Organization, over 10 million people die of cancer each year. Conventional treatment methods such as chemotherapy also result in grave side-effects. A new treatment strategy uses the body's own immune cells, T cells. Modified to include a synthetic receptor, they can then recognize and attack cancer cells. Nevertheless, the process still subjects healthy tissue to unwanted attack as well.
The iGEM project SpecifiCAR, led by Matthias J. Feige, TUM Professor for Cellular Protein Biochemistry, makes use of the fact that modified T cells communicate with one another using synthetic neurotransmitters: Wherever a large number of cells are already fighting the cancer, more of these neurotransmitters are released which in turn activate additional T cells. The iGEM Munich team won the prize for the best software tool with its open source database for these receptors.
The international Genetically Engineered Machine (iGEM) competition has been conducted by the iGEM Foundation since 2003. This year 360 teams from over 40 countries participated.
Speeding up sugar's conversion into fuel
University of Queensland researchers have found a way to more efficiently convert sugarcane into a building block of aviation fuel and other products. By zeroing in on a specific enzyme, a UQ team working in collaboration with the Technical University of Munich (TUM) has sped up the slowest ... more
Possible therapeutic approach to fight incurable blood cancer
Multiple myeloma (MM) is the second most common type of blood cancer. It attacks the plasma cells in the blood. A team at the Technical University of Munich (TUM) has now discovered a mechanism which provides indications of when and why these cells become aggressive. The team is still condu ... more
Biomathematician Fabian Theis receives Leibniz Prize
Mathematician, physicist and information scientist Prof. Fabian Theis has won the 2023 Gottfried Wilhelm Leibniz Prize. The full professor for Biomathematics at the Technical University of Munich (TUM) has been honored for his pioneering work in the analysis, modeling and interpretation of ... more
